Melissa Hughes - Center for Cancer Precision Medicine, Dana-Farber Cancer Institute

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PO1-14-10: Comprehensive Clinicogenomic Characterization of Inflammatory Breast Cancer

Cancer Researchno. 9_Supplement (2024): PO1-14

引用0浏览0引用

Liquid Biopsy Determination of HER2 Status in Breast Cancer: Results from a Novel Epigenomic Platform

Heather Parsons,Sylvan Baca, Anthony D'Ippolito, Hyun-Hwan Jeong, Kalie Smith, Paolo Tarantino,Melissa Hughes, Kerry Sendrick,Corrie Painter, Ji-Heui Seo, Elizabeth Grant, Jamey Guess,Matthew Davidsohn,Gitanjali Lakshminarayanan,Sarah Strauss, Hunter Savignano, John Canniff, Brad Fortunato, Matthew Eaton,Toni Choueiri,Sara Tolaney,Matthew Freedman,Nancy Lin

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Predictors of Exceptional Response to First Line HER2-targeted Therapy for Metastatic Breast Cancer

Stefania Morganti, Tianyu Li,Katheryn Santos,Melissa Hughes,Nolan Priedigkeit,Yvonne Li, Marla Lipsyc-Sharf,Gregory Kirkner,Janet Files, Julie Kasparian, Elizabeth Grant, Gunjan Gupta,Giuseppe Curigliano,Sara Tolaney,Andrew Cherniack,Nabihah Tayob,Nancy Lin,Heather Parsons

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract PO1-03-08: Association of Patient-Reported Triple-Negative Breast Cancer (TNBC) Knowledge with Clinical Trial Participation

Megan Tesch,Noah Graham,Sean Ryan,Melissa Hughes,Eileen Wrabel,Nadine Tung, Steve Lo, Thomas Fynan,Meredith Faggen,Natalie Sinclair, Maria Constantinou,Sarah Sinclair,Nabihah Tayob,Nancy Lin,Ann Partridge,Eric Winer,Sara Tolaney,Ana Garrido-Castro

Cancer Researchno. 9_Supplement (2024): PO1-03

引用0浏览0引用

Abstract PO2-04-01: Predictors of exceptional response to first line HER2-targeted therapy for metastatic breast cancer

Stefania Morganti,Tianyu Li,Katheryn Santos,Melissa Hughes,Nolan Priedigkeit,Yvonne Li,Marla Lipsyc-Sharf,Gregory Kirkner,Janet Files, Julie Kasparian, Elizabeth Grant, Gunjan Gupta,Giuseppe Curigliano,Sara Tolaney,Andrew Cherniack,Nabihah Tayob,Nancy Lin,Heather Parsons

Cancer Researchno. 9_Supplement (2024): PO2-04

引用0浏览0引用

Supplementary Figure S5 from Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies

Bojana Jovanović,Sarah E. Church, Kara M. Gorman, Khrystyna North, Edward T. Richardson, Molly DiLullo,Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu,Gregory Kirkner,Melissa E. Hughes,Nancy U. Lin,Elizabeth A. Mittendorf,Stuart J. Schnitt,Sara M. Tolaney,Shom Goel

crossref（2024）

引用0浏览0引用

Abstract GS03-09: Characterization and proposed therapeutic exploitation of fusion RNAs in metastatic breast cancers

Cancer Researchno. 9_Supplement (2024): GS03-09

引用0浏览0引用

Supplementary Figure S1 from Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies

crossref（2024）

引用0浏览0引用

Association of Patient-Reported Triple-Negative Breast Cancer (TNBC) Knowledge with Clinical Trial Participation

Megan Tesch,Noah Graham,Sean Ryan,Melissa Hughes,Eileen Wrabel,Nadine Tung, Steve Lo, Thomas Fynan,Meredith Faggen,Natalie Sinclair, Maria Constantinou, Sarah Sinclair,Nabihah Tayob,Nancy Lin,Ann Partridge,Eric Winer,Sara Tolaney, Ana Garrido-Castro

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

A Phase 2 Study of Abemaciclib Monotherapy for Patients with Retinoblastoma-Positive (rb Plus ), Triplenegative Metastatic Breast Cancer

Shom Goel,Bojana Jovanovic, Xiangying Chu,Melissa Hughes, Ayesha Mohammed-Abreu, Julie Kasparian,Timothy Erick, Molly DiLullo,Eileen Wrabel,Rinath Jeselsohn,Nabihah Tayob, Stuart Schnitt,Nancy Lin,Sara Tolaney

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn